News
CTSO
0.9802
-2.95%
-0.0298
Weekly Report: what happened at CTSO last week (0715-0719)?
Weekly Report · 3d ago
Weekly Report: what happened at CTSO last week (0708-0712)?
Weekly Report · 07/15 11:02
Weekly Report: what happened at CTSO last week (0701-0705)?
Weekly Report · 07/08 11:03
Why CytoSorbents (CTSO) Stock Is Trading Higher
CytoSorbents Corp (NASDAQ:CTSO) shares are trading higher by 21% to $0.85. The company entered into a new $20 million credit facility with Avenue Capital Group. CTSO has a 52-week high of $4.29.
Benzinga · 07/02 19:31
CytoSorbents Entered Into A New $20M Credit Facility With Avenue Capital Group
Benzinga · 07/02 11:10
CytoSorbents gets new $20M credit facility
Healthcare CytoSorbents gets new $20M credit facility with Avenue Capital. The proceeds are expected to support the company's critical care and cardiac surgery franchise. The agreement has an initial term of three years. Cytosorbents Corporation (CTSO) stock.
Seeking Alpha · 07/02 11:06
CYTOSORBENTS SECURES $20 MILLION CREDIT FACILITY
Reuters · 07/02 11:00
Press Release: CytoSorbents Secures $20 Million Credit Facility
Dow Jones · 07/02 11:00
Press Release: CytoSorbents Secures $20 Million -2-
Dow Jones · 07/02 11:00
Weekly Report: what happened at CTSO last week (0624-0628)?
Weekly Report · 07/01 11:04
CytoSorbents reports regulatory approval of CytoSorb in Taiwan
Healthcare CytoSorbents reports regulatory approval of Cy toSorb in Taiwan by the Taiwan Food and Drug Administration. Approved indications include the extracorporeal removal of cytokines, bilirubin and myoglobin from a patient's circulating blood. Cyto tosorb is approved in the European Union and distributed in 75 countries worldwide.
Seeking Alpha · 06/24 11:43
Cytosorbents Announces The Regulatory Approval Of Cytosorb In Taiwan For Extracorporeal Removal Of Cytokines (e.g. Cytokine Storm, Sepsis), Bilirubin (e.g. Liver Disease), And Myoglobin (e.g. Trauma) From A Patient's Circulating Blood
Benzinga · 06/24 11:19
Weekly Report: what happened at CTSO last week (0617-0621)?
Weekly Report · 06/24 11:11
BRIEF-Cytosorbents Corp Regulatory Approval Of Cytosorb In Taiwan
Reuters · 06/24 11:07
Weekly Report: what happened at CTSO last week (0610-0614)?
Weekly Report · 06/17 11:03
CytoSorbents Announces Immediate Availability Of PuriFi Blood Pump In EU
NASDAQ · 06/13 12:08
CYTOSORBENTS ANNOUNCES LAUNCH AND IMMEDIATE AVAILABILITY OF PURIFI™ BLOOD PUMP IN EUROPEAN UNION
Reuters · 06/13 11:03
Weekly Report: what happened at CTSO last week (0603-0607)?
Weekly Report · 06/10 11:04
Weekly Report: what happened at CTSO last week (0527-0531)?
Weekly Report · 06/03 11:07
Weekly Report: what happened at CTSO last week (0520-0524)?
Weekly Report · 05/27 11:12
More
Webull provides a variety of real-time CTSO stock news. You can receive the latest news about Cytosorbents Corp through multiple platforms. This information may help you make smarter investment decisions.
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis. Its other products include CytoSorb, animal-targeted VetResQ, DrugSorb-ATR and ECOS-300CY. Its other product candidates under development, including CytoSorb XL, BetaSorb, ContrastSorb, DrugSorb, HemoDefend-RBC, HemoDefend-BGA, K+ontrol, and others consist of a cartridge containing adsorbent, porous polymer beads, although the polymers used in these devices are physically different.